The FDA has approved dupilumab to treat allergic fungal rhinosinusitis in adults and children ages 6 years and older. Medscape Medical News Source link : https://www.medscape.com/viewarticle/dupilumab-approved-allergic-fungal-rhinosinusitis-2026a10005zi?src=rss Author : Publish date...
Read more














